Publications by authors named "Feliza Bourguet"

Claim this Profile
C
CT584 Is Not a Protective Vaccine Antigen against Respiratory Chlamydial Challenge in Mice.
Steven Hoang-Phou, Sukumar Pal, Anatoli Slepenkin, Abisola Abisoye-Ogunniyun, Yuliang Zhang, Feliza A Bourguet

Vaccines (Basel)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation in mice of cell-free produced CT584 as a Chlamydia vaccine antigen.
Steven Hoang-Phou, Sukumar Pal, Anatoli Slepenkin, Abisola Abisoye-Ogunniyun, Yuliang Zhang, Feliza Bourguet

bioRxiv· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Inactivation Methods for Rift Valley Fever Virus in Mouse Microglia.
Margarita V Rangel, Feliza A Bourguet, Carolyn I Hall, Dina R Weilhammer

Pathogens· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large-scale application of free energy perturbation calculations for antibody design.
Fangqiang Zhu, Feliza A Bourguet, William F D Bennett, Edmond Y Lau, Kathryn T Arrildt

Sci Rep· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MAVS mediates a protective immune response in the brain to Rift Valley fever virus.
Nicholas R Hum, Feliza A Bourguet, Aimy Sebastian, Doris Lam, Ashlee M Phillips

PLoS Pathog· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of potent and effective synthetic SARS-CoV-2 neutralizing nanobodies.
Maxwell A Stefan, Yooli K Light, Jennifer L Schwedler, Peter R McIlroy, Colleen M Courtney, Feliza A Bourguet

MAbs· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Small-Molecule Inhibitors of SARS-CoV-2 Proteins Using a Computational and Experimental Pipeline.
Edmond Y Lau, Oscar A Negrete, W F Drew Bennett, Brian J Bennion, Monica Borucki, Feliza Bourguet

Front Mol Biosci· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cationic HDL mimetics enhance in vivo delivery of self-replicating mRNA.
Wei He, Angela C Evans, Amy Rasley, Feliza Bourguet, Sandra Peters

Nanomedicine· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-free production of a functional oligomeric form of a major outer-membrane protein (MOMP) for vaccine development.
Wei He, Martina Felderman, Angela C Evans, Jia Geng, David Homan, Feliza Bourguet

J Biol Chem· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re-directing bacterial microcompartment systems to enhance recombinant expression of lysis protein E from bacteriophage ϕX174 in Escherichia coli.
Mimi C Yung, Feliza A Bourguet, Timothy S Carpenter, Matthew A Coleman

Microb Cell Fact· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Genome-Wide Mutations in Ciprofloxacin-Resistant F. tularensis LVS Using Whole Genome Tiling Arrays and Next Generation Sequencing.
Crystal J Jaing, Kevin S McLoughlin, James B Thissen, Adam Zemla, Shea N Gardner, Feliza Bourguet

PLoS One· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression and Association of the Yersinia pestis Translocon Proteins, YopB and YopD, Are Facilitated by Nanolipoprotein Particles.
Matthew A Coleman, Jenny A Cappuccio, Craig D Blanchette, Tingjuan Gao, Erin S Arroyo, Feliza A Bourguet

PLoS One· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluorescence correlation spectroscopy at micromolar concentrations without optical nanoconfinement.
Ted A Laurence, Sonny Ly, Feliza Bourguet, Nicholas O Fischer, Matthew A Coleman

J Phys Chem B· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying interactions of a membrane protein embedded in a lipid nanodisc using fluorescence correlation spectroscopy.
Sonny Ly, Feliza Bourguet, Nicholas O Fischer, Edmond Y Lau, Matthew A Coleman

Biophys J· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controlling the diameter, monodispersity, and solubility of ApoA1 nanolipoprotein particles using telodendrimer chemistry.
Wei He, Juntao Luo, Feliza Bourguet, Li Xing, Sun K Yi

Protein Sci· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of a novel lytic protein encoded by the Bacillus cereus E33L gene ampD as a Bacillus anthracis antimicrobial protein.
Feliza A Bourguet, Brian E Souza, Angela K Hinz, Matthew A Coleman, Paul J Jackson

Appl Environ Microbiol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterizing diffusion dynamics of a membrane protein associated with nanolipoproteins using fluorescence correlation spectroscopy.
Tingjuan Gao, Craig D Blanchette, Wei He, Feliza Bourguet, Sonny Ly

Protein Sci· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of c-type cytochromes involved in anaerobic, bacterial U(IV) oxidation.
Harry R Beller, Tina C Legler, Feliza Bourguet, Tracy E Letain, Staci R Kane

Biodegradation· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis